Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.65 |
| ▸ | NAAA | Q02083 | 2/20 | 0.60 |
| ▸ | CNR1 | P21554 | 1/20 | 0.59 |
| ▸ | CA12 | O43570 | 2/20 | 0.54 |
| ▸ | CA2 | P00918 | 2/20 | 0.54 |
| ▸ | CA9 | Q16790 | 2/20 | 0.54 |
| ▸ | KDM4A | O75164 | 1/20 | 0.54 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | MMP8 | P22894 | 1/20 | 0.53 |
| ▸ | PLAAT5 | Q96KN8 | 1/20 | 0.51 |
| ▸ | PLAAT4 | Q9UL19 | 1/20 | 0.51 |
| ▸ | CA1 | P00915 | 1/20 | 0.51 |
| ▸ | MMP1 | P03956 | 1/20 | 0.51 |
| ▸ | MMP2 | P08253 | 1/20 | 0.51 |
| ▸ | MMP3 | P08254 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28414032 | 1.00 | POLB (0.65) | POLBNAAACNR1CA12CA2 | |
| SCHEMBL9542025 | 0.91 | GLI1 (0.58) | POLBNAAACNR1PLAAT5PLAAT4 | |
| SCHEMBL13883466 | 0.91 | GLI1 (0.58) | POLBNAAACNR1PLAAT5PLAAT4 | |
| SCHEMBL16609239 | 0.89 | NAAA (0.54) | POLBNAAACNR1KDM4A | |
| SCHEMBL17204643 | 0.89 | NAAA (0.54) | POLBNAAACNR1KDM4A | |
| Hydrochloric Acid SCHEMBL17204549 | 0.88 | NAAA (0.52) | POLBNAAACNR1KDM4A | |
| Hydrochloric Acid SCHEMBL17203996 | 0.88 | NAAA (0.52) | POLBNAAACNR1KDM4A | |
| SCHEMBL17209103 | 0.87 | NAAA (0.51) | POLBNAAACNR1CA12CA2 | |
| SCHEMBL10692723 | 0.85 | GAA (0.62) | CNR1KMT2APLAAT5PLAAT4 | |
| SCHEMBL29407117 | 0.84 | SMN1; SMN2 (0.60) | CNR1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0098743-B1 | PHENYL ALPHA-ACYLOXYACETAMIDE DERIVATES AND THEIR THERAPEUTIC USE | Yu, Ruey J., Dr. (US) | 1988-09-28 | — | — | EP | claimed |
| EP-0098743-A1 | Phenyl alpha-acyloxyacetamide derivates and their therapeutic use | Yu, Ruey J., Dr. (US) | 1984-01-18 | — | — | EP | claimed |
| US-9162972-B2 | Method for production of hydroxycarboxylic acid amide compounds and novel arylboronic acid compound | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2015-10-20 | — | — | US | disclosed |
| US-9162972-B2 | Method for production of hydroxycarboxylic acid amide compounds and novel arylboronic acid compound | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2015-10-20 | — | — | US | disclosed |
| US-20150011766-A1 | METHOD FOR PRODUCTION OF HYDROXYCARBOXYLIC ACID AMIDE COMPOUNDS AND NOVEL ARYLBORONIC ACID COMPOUND | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2015-01-08 | — | — | US | disclosed |
| US-20150011766-A1 | METHOD FOR PRODUCTION OF HYDROXYCARBOXYLIC ACID AMIDE COMPOUNDS AND NOVEL ARYLBORONIC ACID COMPOUND | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2015-01-08 | — | — | US | disclosed |
| EP-2816026-A1 | PRODUCTION METHOD FOR HYDROXY-CARBOXYLIC ACID AMIDE COMPOUND, AND NOVEL ARYLBORONIC ACID COMPOUND | National University Corporation Nagoya University (JP) | 2014-12-24 | — | — | EP | disclosed |
| EP-0703899-A1 | ARYLACETAMIDES, PROCESS FOR THEIR PREPARATION, COMPOSITIONS CONTAINING THEM AND THEIR USE AS FUNGICIDES | Hoechst Schering AgrEvo GmbH (DE) | 1996-04-03 | — | — | EP | disclosed |
| WO-1994029267-A1 | ARYLACETAMIDES, PROCESS FOR THEIR PREPARATION, COMPOSITIONS CONTAINING THEM AND THEIR USE AS FUNGICIDES | HOECHST SCHERING AGREVO GMBH (DE) | 1994-12-22 | — | — | WO | disclosed |
| EP-0098743-B1 | PHENYL ALPHA-ACYLOXYACETAMIDE DERIVATES AND THEIR THERAPEUTIC USE | Yu, Ruey J., Dr. (US) | 1988-09-28 | — | — | EP | disclosed |
| US-4518789-A | Phenyl alpha-acyloxyacetamide derivatives and their therapeutic use | YU RUEY J | 1985-05-21 | — | — | US | disclosed |
| EP-0098743-A1 | Phenyl alpha-acyloxyacetamide derivates and their therapeutic use | Yu, Ruey J., Dr. (US) | 1984-01-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150011766-A1 | METHOD FOR PRODUCTION OF HYDROXYCARBOXYLIC ACID AMIDE COMPOUNDS AND NOVEL ARYLBORONIC ACID COMPOUND | HCAR2, HCAR1, NCOR2 | POLB 712/4885NAAA 566/4885CNR1 34/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.